Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Total Liabilities (2024 - 2025)

Carlsmed (CARL) has disclosed Total Liabilities for 2 consecutive years, with $31.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 19.15% year-over-year to $31.3 million, compared with a TTM value of $31.3 million through Dec 2025, up 19.15%, and an annual FY2025 reading of $31.3 million, up 19.15% over the prior year.
  • Total Liabilities was $31.3 million for Q4 2025 at Carlsmed, up from $28.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $66.0 million in Q3 2024 and bottomed at $26.2 million in Q4 2024.